Background There is a large amount of research into and promotion of rational prescribing,
but there is a comparative lack of investigation into deprescribing. The success of …

A World Café workshop was held at the Bruyère Evidence-Based Deprescribing Guidelines
Symposium in March 2018 with 30 participants (researchers, clinicians, policy makers …

Aim Deprescribing is an increasingly common term in the literature, although no specific
accepted definition exists. We aimed to clarify the concept of deprescribing as used in …

Background Inappropriate medication use is common in the elderly and the risks associated
with their use are well known. The term deprescribing has been utilised to describe the …

Implementation science may address some of the limitations that impede the translation of
deprescribing recommendations into practice and policy. Application of principles and …

A Bruyère Evidence-Based Deprescribing Guideline Symposium was held in March 2018;
one component focused on implementing deprescribing guidelines into practice. An …

Polypharmacy is common in older adults and associated with inappropriate medication use,
adverse drug events, medication nonadherence, higher costs, and increased mortality …

Background Deprescribing describes the complex process that is required for the safe and
effective cessation of medications that are likely to cause more harm than benefit …

What is known and objective Deprescribing is the process of discontinuing or reducing the
dosage of medications that are no longer appropriate or aligned with goals of care, which is …

Medical Journal of Australia Page 1 1 MJA 201 (7) · 6 October 2014 Clinical focus Emily
Reeve BPharm(Hons), PhD Former PhD candidate1,2 Sepehr Shakib MB BS(Hons) …